SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001640334-23-000091
Filing Date
2023-01-18
Accepted
2023-01-18 16:26:41
Documents
80
Period of Report
2022-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A lxrp_10qa.htm   iXBRL 10-Q/A 779319
2 CERTIFICATION lxrp_ex311.htm EX-31.1 11783
3 CERTIFICATION lxrp_ex312.htm EX-31.2 11428
4 CERTIFICATION lxrp_ex321.htm EX-32.1 4699
5 CERTIFICATION lxrp_ex322.htm EX-32.2 4850
11 lxrp_10qimg19.jpg GRAPHIC 1567
  Complete submission text file 0001640334-23-000091.txt   4384799

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20221130.xsd EX-101.SCH 50076
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20221130_lab.xml EX-101.LAB 247414
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20221130_cal.xml EX-101.CAL 44675
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20221130_pre.xml EX-101.PRE 208994
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20221130_def.xml EX-101.DEF 101944
74 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_10qa_htm.xml XML 803564
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q/A | Act: 34 | File No.: 001-39874 | Film No.: 23534728
SIC: 2834 Pharmaceutical Preparations